Over 7,500 Yaz Blood Clot Lawsuits Pending In Federal Court

Thursday, September 25, 2014

This month, the Judicial Panel on Multidistrict Litigation released their latest report showing 7,606 Yaz lawsuits are still pending in a federal multidistrict court in the Southern District of Illinois.

The cases had numbered above 10,000 in recent years, until Bayer, who makes Yaz and Yasmin, began a massive settlement program for those suffering blood clot injuries.

Since 2012, the company has paid out over $1.8 billion to nearly 9,000 women and their families, for deep vein thrombosis and pulmonary embolisms caused by the drug.

The number of pending cases remains high though since lawyers are still assisting those who haven’t filed a claim yet.

Last week, Judge David Herndon, who oversees the federal Yaz cases, put pressure on Bayer to step up the settlements by scheduling many unresolved cases for trial next year.

However, lawyers urge anyone who hasn’t yet looked into a claim to do so, as time is running out.


Judicial Panel on Multidistrict Litigation. (September 15, 2014). Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-15-2014.pdf

birth control

Other drugs and devices in the news:

Thursday, January 17, 2019
3M Earplugs
3M Knowingly Harms Troops: Supplies Defective Combat Earplugs

Last summer, the Department of Justice unveiled the details of an ongoing lawsuit and resulting settlement against industrial giant 3M, claiming the company had furnished defective combat earplugs to millions of U.S. troops serving around the world.

Monday, October 8, 2018
FDA Adds Restrictions to Use of Essure Birth Control Implants

The FDA enacted tough new regulations this week aimed at making sure all women who are considering implantation of the Essure birth control device fully understand all the risks and benefits before moving forward.

Get in touch with us.

Call, email or live chat with us today to see how we can help.

Need a quick answer? Call us!
Reach out to us by email.
We are here to help now